Get Healthy!

New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy

Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.

HealthDay
Health News is provided as a service to Sav-Mor Drugs site users by HealthDay. Sav-Mor Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.

Our commitment to patient care and health is priority one here at Sav-Mor Drugs.

We believe in the value of providing personalized service and quality products.


Sav-Mor Drugs
Siboney Commercial Centre, E. Mall Drive and Adventures Way, Freeport, INT
(242) 351-4700 - (242) 351-4707
visa mastercard